[Multidrug-resistant bacteria require new treatment options].
By now multidrug-resistant bacteria are a common cause of infections, especially in immunocompromised patient. These infections have to be treated with last resort antibiotics, such as colistin for the treatment of drug-resistant enterobacteriaceae or acinetobacter spp. Additionally the prevention of infections plays an important role in protecting critically ill patients.